Navigation Links
New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)
Date:5/14/2008

n, with a resultant increase in vascular water retention and blood volume that also contributes to an elevation in blood pressure. BENICAR is a member of the ARB class of antihypertensive medications that help lower blood pressure by blocking the angiotensin II receptor on the blood vessels and antagonizing the release of the hormone which causes salt retention and increased blood volume. BENICAR HCT combines BENICAR with the diuretic hydrochlorothiazide. BENICAR and BENICAR HCT are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. BENICAR HCT is not indicated for initial therapy.

Important Safety Information

USE IN PREGNANCY

When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, BENICAR or BENICAR HCT should be discontinued as soon as possible. See WARNINGS, Fetal/Neonatal Morbidity and Mortality in the prescribing information.

Hypotension in Volume- or Salt-Depleted Patients

In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with BENICAR. Treatment should start under close medical supervision. If hypotension does occur, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline. A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized.

Impaired Renal Function

In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen (BUN) have been reported. There has been no long-term use o
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
2. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
3. St. Jude Study Shows How T Cells Machinery Dials Down Autoimmunity
4. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
5. NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting
6. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
7. Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
8. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
9. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
10. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
11. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sept. 30, 2014  Allakos Inc. announced today ... investment from current investors to fund development of ... completed following achievement of a key, pre-specified milestone ... represents an extension of the company,s Series A ... With this additional financing, Allakos has raised a ...
(Date:9/29/2014)... and DUBLIN , Sept. 29, 2014 ... "Company"), a biotechnology company pioneering the manufacturing both US ... therapies for cancer, HIV/AIDS, opportunistic infections and autoimmune diseases ... from CEO Noreen Griffin The letter follows: ... or "TNIB") received a number of calls from shareholders ...
(Date:9/29/2014)... EU5 Capsule Endoscopy Systems Market Outlook to ... report, "EU5 Capsule Endoscopy Systems Market Outlook to 2020", ... Systems market. The report provides value, in millions of ... US dollars) within market segments - Capsule Endoscopes, Capsule ... The report also provides company shares and distribution shares ...
Breaking Medicine Technology:Allakos Inc. Raises Additional $10 Million to Expand its Portfolio and Fund Development of an Additional Antibody for Allergic and Inflammatory Diseases 2Allakos Inc. Raises Additional $10 Million to Expand its Portfolio and Fund Development of an Additional Antibody for Allergic and Inflammatory Diseases 3Allakos Inc. Raises Additional $10 Million to Expand its Portfolio and Fund Development of an Additional Antibody for Allergic and Inflammatory Diseases 4TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 2TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 3TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 4TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 5TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 6TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 7TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 8EU5 Capsule Endoscopy Systems Market Outlook to 2020 2EU5 Capsule Endoscopy Systems Market Outlook to 2020 3
... VIEJO, Calif., May 14, 2012  Bausch + Lomb, ... Barr Global President of the company,s Surgical business.  ... full suite of ophthalmic surgical products, intraocular lenses ... names as enVista™ Crystalens®, Stellaris® ...
... N.Y., May 14, 2012   Pharmaceutical manufacturers and ... requiring reporting on drug product samples distribution using XML, ... To help the pharmaceutical industry cope with the ... for ongoing Standard SPL filings, Data Conversion Laboratory (DCL) ...
Cached Medicine Technology:Bausch + Lomb Names John Barr Global President Surgical 2Bausch + Lomb Names John Barr Global President Surgical 3Coping With New FDA Mandates For Drug Sample Distribution 2
(Date:9/30/2014)... 2014 Julie Kuriakose, MD; ... , will discuss how restaurants can become more allergy-friendly ... dietary restrictions at the 2014 Allergy Eats Food ... October 21 in New York City. , “I’m extremely ... to such an engaged industry audience. As food allergies ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 In ... well as better data capture and management functions ... ClinCapture electronic data capture (EDC) system. ClinCapture offers ... ability to easily manage clinical trial data and ... cement Synergy’s position as the leading clinical research ...
(Date:9/30/2014)... From October 12-15, MMS, Inc. (Medical ... SHSMD Connections Annual Conference in San Diego, California. ... Development (SHSMD) is proud to host the event of ... and strategic planning professionals in San Diego this fall: ... conference is a four-day event designed to equip ...
(Date:9/30/2014)... Bibliomotion is proud to announce the release of ... Social Age by Frank Guglielmo and Sudhanshu ... authors apply their leadership coaching experience to introduce Social Leadership ... and behaviors that leaders must adopt in order to thrive ... read a review of The Social Leader in Dialogue Reviews. ...
(Date:9/30/2014)... JACKSON, Tenn. (PRWEB) September 30, 2014 ... Oct. 4, from 10 a.m. to 2 p.m. at ... Pinson). Woodmen of the World sponsors this family-oriented festival, ... free, and the festival will feature a car show, ... climbing wall, hayride and children’s games. Also, Lightning McQueen ...
Breaking Medicine News(10 mins):Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 2Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 3Health News:Synergy Research Group Opts for Clinovo 2Health News:Synergy Research Group Opts for Clinovo 3Health News:MMS, Inc. (Medical Marketing Service) to Attend the 2014 SHSMD Connections Annual Conference in October 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 3Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 4Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 5Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 6
... coverage and other problems persist, analysis shows, , WEDNESDAY, July ... access to prescription drug coverage has ballooned since Medicare,s Part ... new analysis finds, yet seniors, ability to pay for needed ... rising drug plan costs. , "Based on nearly four years ...
... in the regulation of cell death has been identified ... led them to recommend caution when drugs called IAP ... liver conditions. , A team led by Professor Andreas ... has found that XIAP (X-chromosome-linked inhibitor of apoptosis protein) ...
... , Presidential Health Advisor , s Writings Support ... DALLAS, July 22 On the cusp of President Obama,s news conference tonight, ... care reform plan may result in denying care to a significant number of ... Administration does not consider doctors the best judges of the type of health ...
... WEDNESDAY, July 22 (HealthDay News) -- One part of the ... when deadly plaque builds up, but two other sections don,t, ... Wake Forest University Baptist Medical Center have found. , ... and left carotid arteries expands by 11 percent, on average, ...
... , , LANTANA, Fla., July ... (IHPA), announced today the launching of the , ... Get the Number , campaign is an ... for when buying storm and hurricane protection," Johnston said. "Consumers ...
... , , OAK BROOK, ... gastroenterologists, gastroenterology nurses and gastroenterology fellows, announces enhanced site content ... , , NAAP describes the ... of a physician, or by a physician or nurse other ...
Cached Medicine News:Health News:Medicare Drug Plan Still Needs Work 2Health News:Medicare Drug Plan Still Needs Work 3Health News:Critical link in cell death pathway revealed 2Health News:NCPA: White House Has Ideas on How to Ration Health Care 2Health News:Carotid Artery Sections React Differently to Plaque 2Health News:IHPA Launches Consumer Awareness Campaign for Hurricane Protection 2Health News:IHPA Launches Consumer Awareness Campaign for Hurricane Protection 3Health News:SedationFacts.org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 2Health News:SedationFacts.org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 3Health News:SedationFacts.org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 4